Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Role of BAP1 in pancreatic cancer (ChIP-seq Human)

ABSTRACT: Role of BAP1 in pancreatic cancer (ChIP-seq Human)

PROVIDER: PRJNA493095 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7901190.fastq.gz	Fastqsanger.gz
	SRR7901191.fastq.gz	Fastqsanger.gz
	SRR7901192.fastq.gz	Fastqsanger.gz
	SRR7901193.fastq.gz	Fastqsanger.gz
	SRR7901194.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Role of BAP1 in pancreatic cancer

Project description:Role of BAP1 in pancreatic cancer

| PRJNA491700 | ENA

Role of BAP1 in pancreatic cancer (ChIP-seq Mus musculus)

Project description:Role of BAP1 in pancreatic cancer (ChIP-seq Mus musculus)

| PRJNA498217 | ENA

Role of BAP1 in pancreatic cancer (PrimeView)

Project description:Role of BAP1 in pancreatic cancer (PrimeView)

| PRJNA491699 | ENA

Role of BAP1 in pancreatic cancer (ChIP-seq Human)

Project description:We found that BAP1 (BRCA1 Associated Protein-1) shows loss of heterozygosity in over 25% of pancreatic cancer patients and functions as tumor suppressor. Conditional deletion of Bap1 in murine pancreas led to genomic instability, accumulation of DNA damage, and an inflammatory response that evolved to pancreatitis with full penetrance. Concomitant expression of oncogenic KrasG12D led to malignant transformation and development of invasive and metastatic pancreatic cancer. At the molecular level, BAP1 maintains the integrity of the exocrine pancreas by regulating genomic stability and its loss confers sensitivity to radio- and platinum-based therapies.

2020-04-14 | GSE120460 | GEO

Role of BAP1 in pancreatic cancer (MoGene-2_0)

Project description:Role of BAP1 in pancreatic cancer (MoGene-2_0)

| PRJNA491696 | ENA

Role of BAP1 in pancreatic cancer (MoGene-2_0)

Project description:Transcriptional profile of murine Bap1 null pancreatic cancer cell lines We found that BAP1 (BRCA1 Associated Protein-1) shows loss of heterozygosity in over 25% of pancreatic cancer patients and functions as tumor suppressor. Conditional deletion of Bap1 in murine pancreas led to genomic instability, accumulation of DNA damage, and an inflammatory response that evolved to pancreatitis with full penetrance. Concomitant expression of oncogenic KrasG12D led to malignant transformation and development of invasive and metastatic pancreatic cancer. At the molecular level, BAP1 maintains the integrity of the exocrine pancreas by regulating genome stability and its loss confers sensitivity to radio- and platinum-based therapies

2020-04-14 | GSE120075 | GEO

Role of BAP1 in pancreatic cancer (ChIP-seq Mus musculus)

2020-04-14 | GSE121709 | GEO

Role of BAP1 in pancreatic cancer (PrimeView)

Project description:Transcriptional profile of PANC1 cells with CRISPR/Cas9 mediated deletion of BAP1 We found that BAP1 (BRCA1 Associated Protein-1) shows loss of heterozygosity in over 25% of pancreatic cancer patients and functions as tumor suppressor. Conditional deletion of Bap1 in murine pancreas led to genomic instability, accumulation of DNA damage, and an inflammatory response that evolved to pancreatitis with full penetrance. Concomitant expression of oncogenic KrasG12D led to malignant transformation and development of invasive and metastatic pancreatic cancer. At the molecular level, BAP1 maintains the integrity of the exocrine pancreas by regulating genome stability and its loss confers sensitivity to radio- and platinum-based therapies.

2020-04-14 | GSE120078 | GEO

Role of histone demethylase Kdm6a in pancreatic cancer - ChIP-Seq

Project description:Role of histone demethylase Kdm6a in pancreatic cancer - ChIP-Seq

| PRJNA413702 | ENA

Genome wide binding sites of BAP1, HCF1 and OGT

Project description:We report the genome wide binding sites of BAP1, HCF1 and OGT in bone marrow derived macrophages. De-ubiquitinating enzyme BAP1 is mutated in a hereditary cancer syndrome with increased risk of mesothelioma and uveal melanoma. Somatic BAP1 mutations occur in various malignancies. We show that mouse Bap1 gene deletion is lethal during embryogenesis, but systemic or hematopoietic-restricted deletion in adults recapitulates features of human myelodysplastic syndrome (MDS). Knockin mice expressing BAP1 with a 3xFlag tag revealed that BAP1 interacts with host cell factor–1 (HCF-1), O-linked N-acetylglucosamine transferase (OGT), and the polycomb group proteins ASXL1 and ASXL2 in vivo. OGT and HCF-1 levels were decreased by Bap1 deletion, indicating a critical role for BAP1 in stabilizing these epigenetic regulators. Human ASXL1 is mutated frequently in chronic myelomonocytic leukemia (CMML) so an ASXL/BAP1 complex may suppress CMML. A BAP1 catalytic mutation found in a MDS patient implies that BAP1 loss of function has similar consequences in mice and humans. For BAP1, bone marrow derived macrophages were used differentiated from bone marrow cells of BAP1-3X Flag Tagged KI mice we generated. For OGT and HCF1, bone marrow derived macrophages were used from BAP1 WT mice.

2012-11-07 | E-GEOD-40723 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data